TEL AVIV, Israel, Oct. 07, 2026 (GLOBE NEWSWIRE) -- . (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that ...
About NeuroThera Labs Inc. NeuroThera is a clinical-stage pharmaceutical company focused on developing novel therapeutics for central nervous system disorders and other underserved health conditions ...
Full one-year results from the KYSA-8 registrational trial in stiff person syndrome to be reported, demonstrating sustained clinical benefit and ...
A comprehensive new study identifies five DEVIL family genes in rice and shows that their haplotype diversity across 3,010 ...
Unrelated virus. (Heather Davies/SPL/Getty Images) Some pieces of our DNA can copy themselves into new locations. Copies derived from one gene active in human brain cells appear to have taken that ...
Three preprints expand the list of high-confidence autism-linked genes and reveal how variants in these genes contribute to ...
AI drug repurposing cuts development time, costs and risk by analyzing multi-omics and clinical data, while precision medicine, rare diseases and cloud adoption drive opportunities.Dublin, Oct. 07, ...
DNA samples from Jonathan the 194-year-old tortoise reveal gene variants and epigenetic changes that could contribute to his ...
Series C Convertible Non-Voting Preferred Stock, eliminating the holder's optional redemption right. This change is expected to allow the company to reclassify approximately $9.0 million of the ...
A new study integrates single-cell transcriptomics with human tissue and mouse model validation to show that ...
Currently, SXTC is trading at $6.60, up 456.59%. VERAXA Biotech develops next-generation antibody-based cancer therapies, including BiTAC T cell engagers and bispecific antibody-drug conjugates.The ...
Late-breaking data from positive Phase III REMODEL-1/-2 trials will show efficacy and safety profile of remibrutinib in RMS ; Novartis to hold virtual investor event highlighting ...